“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-5760
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature” ; volume:11 ; number:1 ; day:24 ; month:5 ; year:2021 ; pages:1-9 ; date:12.2021
Journal of ophthalmic inflammation and infection ; 11, Heft 1 (24.5.2021), 1-9, 12.2021
- Urheber
-
Clarke, Sarah L. N.
Mageean, Katie S.
Carlton, Henry
Simonini, Gabriele
Sharp, Gemma C.
Relton, Caroline L.
Ramanan, Athimalaipet V.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12348-021-00247-1
- URN
-
urn:nbn:de:101:1-2021091807311955080729
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Clarke, Sarah L. N.
- Mageean, Katie S.
- Carlton, Henry
- Simonini, Gabriele
- Sharp, Gemma C.
- Relton, Caroline L.
- Ramanan, Athimalaipet V.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Juvenile idiopathic arthritis-associated uveitis
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathic arthritis associated with a mutation in GATA3
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis
Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
Juvenile idiopathic arthritis-associated uveitis
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathic arthritis associated with a mutation in GATA3
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis
Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
Juvenile idiopathic arthritis-associated uveitis
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathic arthritis associated with a mutation in GATA3
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis
Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination